Collaboration in Cancer Care: Navigating Hospital-Community Practice Partnerships
Leah LawrencePrint | July 14, 2025

Community oncologists and their practices are an integral part of the cancer
care continuum, caring for 50% to 80% of patients diagnosed with cancer.
Blood Cancers Today spoke with several oncologists about the types of
partnerships and the benefits and drawbacks to each.

Advertisement
Advertisement

Advertisement
Advertisement
Editorial Board

Podcasts

Alexey V. Danilov, MD, PhDChronic Lymphocytic Leukemia | July 14, 2025
Dr. Alexey Danilov discusses new therapies and ongoing challenges in the evolving CLL treatment landscape.
Saad Z. Usmani, MD, MBA, FACPMyeloma | July 3, 2025
Experts discuss quadruplet therapy, MRD, and evolving transplant decisions in newly diagnosed multiple myeloma.
Nichole TuckerAcute Myeloid Leukemia | June 30, 2025
Dr. Amir Fathi discusses oral regimens and future AML therapy trends in this Editor’s Special of The HemOnc Pulse.
Rahul Banerjee, MD, FACPThe HemOnc Pulse | June 30, 2025
Can tech bridge the cancer care gap? Dr. Banerjee and Dr. Longmire explore solutions for drug accessibility.
Rahul Banerjee, MD, FACPAggressive B-Cell Lymphoma | June 30, 2025
Experts explore CAR T therapy challenges and the future of lymphoma care beyond CD19-targeted treatments.
Rahul Banerjee, MD, FACPAcute Myeloid Leukemia | June 30, 2025
Experts discuss early detection in myeloid malignancies, from current challenges to future innovations.
Rahul Banerjee, MD, FACPMyelodysplastic Syndromes | June 5, 2025
At The HemOnc Pulse Live!, experts debate key controversies in MDS care, from frontline therapy to emerging treatments.
Rahul Banerjee, MD, FACPMyeloma | May 5, 2025
Gurbakhash Kaur, MD joins the host of The HemOnc Pulse Live! for a comprehensive discussion about the RedirecT-1 trial.

Trending on MashupMD